Current standard of care

OTHER8 trials

Conditions

Acral NevusAtrial FibrillationAutism Spectrum DisorderBreast CancerCOVID-19Digital UlcerHepato Cellular Carcinoma (HCC)METASTATIC CANCER

Phase 2

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

RecruitingNCT07302919

University Hospital, Basel, SwitzerlandHepato Cellular Carcinoma (HCC)

Start: 2026-02-16End: 2028-06-01Target: 152Updated: 2026-03-02

Phase 3

Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

TerminatedNCT05271929

Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-HessenCOVID-19

Start: 2022-04-01End: 2024-06-17Updated: 2024-10-29

Phase 4

Acute Labetalol Use in Preeclampsia

TerminatedNCT03872336

Albany Medical CollegePreeclampsia With Severe Features

Start: 2019-02-18End: 2020-07-20Updated: 2020-07-22

Unknown Phase

Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

CompletedNCT02857400

Institut Claudius RegaudMETASTATIC CANCER

Start: 2017-07-21End: 2022-08-30Updated: 2026-04-14

Executive Function Intervention for High School Students With ASD

CompletedNCT03199937

Children's National Research InstituteAutism Spectrum Disorder

Start: 2015-07-11End: 2019-06-30Updated: 2020-04-10

Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients

CompletedNCT04106609

Karen WondersBreast Cancer

Start: 2019-08-23End: 2021-10-28Updated: 2024-06-07

Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma.

TerminatedNCT05181644

EmoledAcral Nevus, Digital Ulcer, Scleroderma +1

Start: 2022-04-22End: 2024-03-06Updated: 2024-06-07

Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial

Not yet recruitingNCT06377046

Maastricht University Medical CenterAtrial Fibrillation, Pacemaker DDD, Paroxysmal Atrial Fibrillation +2

Start: 2024-05-31End: 2026-05-31Target: 50Updated: 2024-04-22

Related Papers

<scp>SARS</scp> ‐ <scp>CoV</scp> ‐2 convalescent plasma for the controlled clinical trial “ <scp>COVIC</scp> ‐19”: Experience from collection of very high‐titer plasma from superimmunized individuals

Transfusion2025-09-12

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial.

2025-02-2711 citations

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial

BMJ Open2023-04-017 citations

Study protocol of the CREDO randomised controlled trial: evaluation of a structured return home consultation for patients suffering from metastaticcancer

BMJ Open2023-01-01

Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19

Frontiers in Immunology2022-10-066 citations